Rhumbline Advisers PREVAIL THERAPEUTICS INC- CVR Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024
Number of Shares
13,291
Previous 13,291 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
N/A
-153 Reduced 1.14%
13,291 $0
Q2 2021

Aug 05, 2021
SELL
N/A
-770 Reduced 5.42%
13,444 $0
Q1 2021

May 06, 2021
BUY
N/A
14,214 New
14,214 $0
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email